Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ischemic Heart Disease

  Free Subscription


03.08.2026

2 Am Heart J
5 Am J Cardiol
6 Angiology
1 Arterioscler Thromb Vasc Biol
3 Atherosclerosis
1 BMJ
1 Can J Cardiol
1 Cardiovasc Res
1 Catheter Cardiovasc Interv
13 Circ J
4 Circ Res
9 Circulation
4 Clin Cardiol
3 Int J Cardiol
7 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
1 J Thorac Cardiovasc Surg
1 JAMA
1 Lancet
9 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. RODRIGO ZONI C, Mukherjee D, Gulati M
    Reconsidering Fibrinolysis in Selected Patients with Non-ST-Elevation Acute Coronary Syndrome: A Hypothesis-Generating, Research-Based Framework.
    Am Heart J. 2026 Jul 31:107548. doi: 10.1016/j.ahj.2026.107548.
    PubMed         Abstract available

  2. WONG JA, Conen D, Doumouras A, Van Reekum E, et al
    Rationale, Design, and Experiences from the Vanguard Phase of the Bariatric Surgery for the Reduction of Cardiovascular Events (BRAVE) Trial.
    Am Heart J. 2026 Jul 25:107544. doi: 10.1016/j.ahj.2026.107544.
    PubMed         Abstract available


    Am J Cardiol

  3. RODRIGUES FB, Machado MN, Bruetto RG, Maia LN, et al
    Sixth-Generation Cardiac Troponin T and Clinical Decision-Making in Acute Chest Pain: Toward an Integrated Approach.
    Am J Cardiol. 2026;273:138-140.
    PubMed         Abstract available

  4. MURASATO Y, Higashi K, Sugino H, Arikawa M, et al
    Chronic Kidney Disease Stage-Specific Risk and Clinical Presentation in Left Main Coronary Intervention: Insights from the LM-JANHO Registry.
    Am J Cardiol. 2026 Jul 31:S0002-9149(26)00488.
    PubMed         Abstract available

  5. VICHOS T, Strepkos D, Alexandrou M, Carvalho PEP, et al
    Sex Differences in Clinical Outcomes after Bifurcation Percutaneous Coronary Intervention: Findings from the PROGRESS-BIFURCATION Registry.
    Am J Cardiol. 2026 Jul 30:S0002-9149(26)00487.
    PubMed         Abstract available

  6. FAIZAN MA, Rehman T, Humayun Z, Dandamudi M, et al
    Sex Differences in Access-site and Clinical Outcomes Following Transradial Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2026 Jul 28:S0002-9149(26)00477.
    PubMed         Abstract available

  7. KAUR H, Carvalho PEP, Strepkos D, Alexandrou M, et al
    Impact of Proximal Optimization Technique in Provisional Bifurcation Percutaneous Coronary Intervention: Insights from PROGRESS-BIFURCATION Registry.
    Am J Cardiol. 2026 Jul 27:S0002-9149(26)00478.
    PubMed         Abstract available


    Angiology

  8. YANG J, Yao W, Li L, Yue Y, et al
    Arterial Stiffness and Physical Activity-Related Cardiovascular Risk: A Sex- and Gender-Informed Perspective.
    Angiology. 2026 Jul 27:33197261471991. doi: 10.1177/00033197261471991.
    PubMed        

  9. DING Q, Zhang W, Tian N
    Comment on: Evaluation of Cardiovascular Risk Scores and Their Association With Vascular Structural Changes in Patients With Retinal Vein Occlusion.
    Angiology. 2026 Jul 27:33197261474634. doi: 10.1177/00033197261474634.
    PubMed        

  10. OYAMA Y, Ueki Y, Kuwahara K
    Reply: Association Between Achilles Tendon Thickness as Assessed by Ultrasound and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention.
    Angiology. 2026 Jul 28:33197261475809. doi: 10.1177/00033197261475809.
    PubMed        

  11. TEBER MK, Aydin MZ
    Bilateral Anterior Tragal Crease Is Associated With Coronary Revascularization in Patients With Stable Angina Pectoris.
    Angiology. 2026 Jul 28:33197261474644. doi: 10.1177/00033197261474644.
    PubMed         Abstract available

  12. ANG SP, Chia JE, Mukherjee D
    Author Reply to Letter: Outcomes of Kidney Transplant Recipients Undergoing Percutaneous Coronary Intervention.
    Angiology. 2026 Jul 29:33197261473782. doi: 10.1177/00033197261473782.
    PubMed        

  13. WANG Q, Chen D, Li T
    Exploring the Potential Role of SLC25A25-AS1 in Acute Coronary Syndrome.
    Angiology. 2026 Jul 29:33197261471988. doi: 10.1177/00033197261471988.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  14. ZOU J, Zhu D, Cheng X, Cheng K, et al
    Bioengineering Approaches for Nanomedicine Delivery in Therapy of Myocardial Infarction.
    Arterioscler Thromb Vasc Biol. 2026 Jul 30. doi: 10.1161/ATVBAHA.126.324247.
    PubMed         Abstract available


    Atherosclerosis

  15. GOULD KL, Johson NP
    Quantitative PET coronary flow capacity and comprehensive management of chronic CAD: Lessons from the randomized CENTURY trial.
    Atherosclerosis. 2026;419:120831.
    PubMed         Abstract available

  16. REVAIAH PC, Vengrenyuk Y, Santosh VK, Karki M, et al
    Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.
    Atherosclerosis. 2026;419:120836.
    PubMed         Abstract available

  17. WANG W, Sun Y, Chang K, Zheng Z, et al
    Therapeutic targets for atherosclerotic coronary artery disease: druggable genome-wide Mendelian randomization analysis.
    Atherosclerosis. 2026;419:120810.
    PubMed         Abstract available


    BMJ


  18. No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
    BMJ. 2026;394:e100400.
    PubMed        


    Can J Cardiol

  19. WANG J, Li C
    Clarification of Methodological Considerations in Angio-IMR Prognosis after Acute Myocardial Infarction.
    Can J Cardiol. 2026 Jul 25:S0828-282X(26)01046.
    PubMed        


    Cardiovasc Res

  20. LE GOUGE K, Ashour D, Heinrichs M, Stys P, et al
    A distinct T cell receptor signature associates with cardiac outcome in myocardial infarction patients.
    Cardiovasc Res. 2026 Jul 29:cvag162. doi: 10.1093.
    PubMed        


    Catheter Cardiovasc Interv

  21. NOORI M, Hougaard M, Maehara A, Troan J, et al
    Multimodality Intravascular Imaging Guidance (NIRS-IVUS-OCT) Compared to Angiography-Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The NIRVUS Trial.
    Catheter Cardiovasc Interv. 2026 Jul 28. doi: 10.1002/ccd.70765.
    PubMed         Abstract available


    Circ J

  22. KATO K, Yamamoto K, Miyakoda K, Tamura N, et al
    Acute and Chronic Management of Spontaneous Coronary Artery Dissection.
    Circ J. 2026;90:949-955.
    PubMed         Abstract available

  23. ABE K, Kitahara H, Tateishi K, Saito Y, et al
    Prognostic Impact of Achilles Tendon Thickening After Percutaneous Coronary Intervention Compared Between Acute and Chronic Coronary Syndromes.
    Circ J. 2026;90:1107-1109.
    PubMed         Abstract available

  24. YAP NAL, Bourantas CV, Losdat S, Ng NYJ, et al
    Comparison of Atheroma Burden Changes Using Conventional vs. End-Diastolic Intravascular Ultrasound Segmentation?- Post Hoc Analysis of the PACMAN-AMI Study.
    Circ J. 2026;90:1010-1021.
    PubMed         Abstract available

  25. KANAJI Y, Yamaji K, Kunimura A, Usui E, et al
    Prognostic Impact of COVID-19 on Patients With Acute Coronary Syndrome Undergoing Emergent Percutaneous Coronary Intervention?- Insights From the J-PCI Nationwide Registry.
    Circ J. 2026;90:1066-1075.
    PubMed         Abstract available

  26. ZHAI M, Bai F, Yan R, Liu M, et al
    Monocyte Immunometabolic Axis Linking Type 2 Diabetes to Coronary Artery Disease Revealed by Multi-Omics Integration and Mendelian Randomization.
    Circ J. 2026;90:1076-1088.
    PubMed         Abstract available

  27. NISHINO M, Egami Y, Nohara H, Kawanami S, et al
    Assessment of and Factors Contributing to Adequate Endothelization After Drug-Eluting Stent Implantation.
    Circ J. 2026;90:956-965.
    PubMed         Abstract available

  28. TANIGUCHI M, Taruya A, Kitahara C, Ota S, et al
    Cathelicidin Links Visceral Fat Accumulation and Coronary Artery Disease.
    Circ J. 2026;90:1089-1099.
    PubMed         Abstract available

  29. ITO T, Yokoi M, Kitada S, Kawada Y, et al
    Time-Dependent Analysis of Blood Sampling to Detect Metabolic Ischemia?- Serial Coronary Artery-Coronary Sinus Lactate Analysis During Acetylcholine Provocation.
    Circ J. 2026;90:1110-1112.
    PubMed         Abstract available

  30. KOBA S, Yokota Y, Satoh N, Ito Y, et al
    Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia.
    Circ J. 2026;90:999-1009.
    PubMed         Abstract available

  31. EOM J, Kang DO, Nam HS, Lee W, et al
    Lesion-Specific Prediction of Segmental Fractional Flow Reserve Using Deep Learning and Optical Coherence Tomography-Derived Features.
    Circ J. 2026;90:1025-1032.
    PubMed         Abstract available

  32. KAKIMOTO Y, Natsuaki M, Node K, Otake H, et al
    Clinical Outcomes After Drug-Eluting Stent Thrombosis in Patients on Hemodialysis?- Insights From the REAL-ST Registry.
    Circ J. 2026;90:969-977.
    PubMed         Abstract available

  33. SABER QAYED K, Lien CW, Wang J, Kao HL, et al
    Efficacy of Primary Retrograde Approach in Complex Chronic Total Occlusions With Unfavorable Antegrade Characteristics and Feasible Interventional Collaterals.
    Circ J. 2026;90:978-987.
    PubMed         Abstract available

  34. ZHANG D, Yi B, He L, Xu Y, et al
    Non-Culprit Lesion Plaque Vulnerability Progression and Regression Assessed by Serial Optical Coherence Tomography Imaging.
    Circ J. 2026;90:1033-1043.
    PubMed         Abstract available


    Circ Res

  35. BINEK A, Angel PM
    Single Cell Proteomics to Spatial Multiomics in Cardiovascular Disease: Foundations, Technologies, and Biological Insights.
    Circ Res. 2026;139:e327684.
    PubMed         Abstract available

  36. YAN X, Zhang H, Fan Q, Hu J, et al
    Correction to: Dectin-2 Deficiency Modulates Th1 Differentiation and Improves Wound Healing After Myocardial Infarction.
    Circ Res. 2026;139:e000763.
    PubMed        

  37. PARKER SJ, Van Eyk JE
    Defining Actionable Cell States in Cardiovascular Disease Through Single-Cell and Spatial Technologies.
    Circ Res. 2026;139:e329382.
    PubMed        

  38. MA M, Lian Y, Shang E, Xue C, et al
    Decoding Cardiovascular Disease Through Spatial Proteomics.
    Circ Res. 2026;139:e327475.
    PubMed         Abstract available


    Circulation

  39. VERGHESE D, Trujillo R, Abraham D, McClelland RL, et al
    Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans Compared With Gated Scans and Incidence of Cardiovascular Events.
    Circulation. 2026;154:302-312.
    PubMed         Abstract available

  40. NDUMELE CE, Rangaswami J, Rodriguez F
    Cardiovascular-Kidney-Metabolic Syndrome: A User's Guide to the Guidelines.
    Circulation. 2026;154:409-412.
    PubMed        

  41. POWELL-WILEY TM, Williams M, Davis EM
    Telehealth for Community-Engaged Cardiovascular Care in Rural Populations.
    Circulation. 2026;154:400-404.
    PubMed        

  42. HUFFMAN MD, Vijay A, Mahmoud Z
    2026 Cardiovascular-Kidney-Metabolic Guidelines: Practical Implementation Strategies.
    Circulation. 2026;154:413-415.
    PubMed        

  43. LLOYD-JONES DM
    Cardiovascular-Kidney-Metabolic Syndrome: A Historic Perspective.
    Circulation. 2026;154:416-419.
    PubMed        

  44. GANESH A, Sujanthan S, Muir RT, Joundi RA, et al
    Major Adverse Cognitive Events (MACE-Cog): A New "MACE" Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke.
    Circulation. 2026;154:378-394.
    PubMed         Abstract available

  45. RODRIGUEZ F, Langlotz CP
    Opportunistic Coronary Artery Calcium Screening: Time for Clinical Implementation.
    Circulation. 2026;154:313-315.
    PubMed        

  46. BREWER LC, Joseph JJ, Cooper LA
    Cardiovascular-Kidney-Metabolic Syndrome: Population and Policy Implications: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome.
    Circulation. 2026;154:405-408.
    PubMed        

  47. STEINHAUSER ML
    Translational Cardiovascular Science for the Circulation Community.
    Circulation. 2026;154:299-300.
    PubMed        


    Clin Cardiol

  48. MURTAZA M, Rasool MM, Ali SME, Farhan M, et al
    National Trends & Disparities in Ischemic Heart Disease & Cardiac Arrhythmias Related Mortality in the United States From 1999 to 2024: A CDC Wonder Analysis.
    Clin Cardiol. 2026;49:e70427.
    PubMed         Abstract available

  49. ZAHRAN A, Amer S, Bdair M, Hameedi S, et al
    The Predictive Value of Platelet-to-Lymphocyte Ratio Before and After Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study in Palestine.
    Clin Cardiol. 2026;49:e70422.
    PubMed         Abstract available

  50. BAI Y, Liu C, Feng L
    Comment on "Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome".
    Clin Cardiol. 2026;49:e70428.
    PubMed        

  51. WANG Q, Lei Y, Zhou Q, Long Y, et al
    Dynamic Co-Evolution of Obesity-Metabolic-Inflammatory for Cardiovascular Disease Risk Stratification in Middle-Aged and Older Adults: A Data-Driven Joint Trajectory Analysis.
    Clin Cardiol. 2026;49:e70429.
    PubMed         Abstract available


    Int J Cardiol

  52. SIMIONI L, Loureiro T, Faucherre Y, Cioffi GM, et al
    Impact of obesity on 1-year major adverse cardiac events after primary PCI for STEMI.
    Int J Cardiol. 2026 Jun 26:134644. doi: 10.1016/j.ijcard.2026.134644.
    PubMed         Abstract available

  53. SHIN ES, Kim S, Kang DO, Kim TH, et al
    Clinical outcomes of intravascular imaging-guided versus angiography-guided drug-coated balloon angioplasty for de novo coronary lesions.
    Int J Cardiol. 2026;461:134663.
    PubMed         Abstract available

  54. RANASINGHE S, Tjoe B, Chang J, Cook-Wiens G, et al
    Left ventricular end-diastolic pressure in women with ischemia and no obstructive coronary artery disease: The women's ischemia syndrome evaluation - Coronary microvascular dysfunction study (WISE-CVD).
    Int J Cardiol. 2026;461:134672.
    PubMed         Abstract available


    J Am Coll Cardiol

  55. MAZIDI M, Wright N, Pozarickij A, Millwood IY, et al
    Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for Ischemic Heart Disease.
    J Am Coll Cardiol. 2026 Jul 20:S0735-1097(26)06771.
    PubMed         Abstract available

  56. YOSHIJI S, Clarke SL
    Triangulating Evidence in Proteome-Wide Mendelian Randomization for Cardiovascular Disease: Insights Across Ancestries and Modalities.
    J Am Coll Cardiol. 2026 Jun 30:S0735-1097(26)06764.
    PubMed        

  57. WEN B, Wu Y, Lavigne E, Coelho M, et al
    Compound Exposure to Extreme Heat and Substantial Landscape Fire-Sourced Air Pollution on Cardiovascular Mortality.
    J Am Coll Cardiol. 2026 Jul 19:S0735-1097(26)06772.
    PubMed         Abstract available

  58. CHU L
    Heat Plus Fire: A Compound Hazard Threatening Cardiovascular Health.
    J Am Coll Cardiol. 2026 Jul 16:S0735-1097(26)06836.
    PubMed        

  59. KOLLIAS A, Krystallaki D, Tsaganos T
    Lipoprotein(a) and Cardiovascular Risk Gradient Across Coronary Artery Calcium Strata.
    J Am Coll Cardiol. 2026 Jul 16:S0735-1097(26)06978.
    PubMed        

  60. MARINACCI LX, Clinch K, Dar M, Prakash-Zawisza V, et al
    Preventive Cardiovascular Care Delivery and Medicaid Accountable Care Organizations: A Difference-in-Differences Analysis.
    J Am Coll Cardiol. 2026 Jul 22:S0735-1097(26)06896.
    PubMed        

  61. BHATIA HS, Fan Y, Wong ND
    REPLY: Lipoprotein(a) and Cardiovascular Risk Gradient Across Coronary Artery Calcium Strata.
    J Am Coll Cardiol. 2026 Jul 22:S0735-1097(26)06977.
    PubMed        


    J Cardiovasc Pharmacol

  62. DE FILIPPO O, Bruno F, Giacobbe F, Beccuti G, et al
    Incretin-based therapies, alcohol and tobacco use, and acute substance-related events: emerging implications for cardiovascular medicine.
    J Cardiovasc Pharmacol. 2026 Jul 28. doi: 10.1097/FJC.0000000000001862.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  63. ALUR-GUPTA S, DiTosto JD, Busse KR, Lewey J, et al
    Manuscript Title: Social Determinants of Health and Cardiovascular Disease in Women with Polyendocrine metabolic ovarian syndrome.
    J Clin Endocrinol Metab. 2026 Jul 30:dgag308. doi: 10.1210.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  64. HWANG HY, Cho H, Sohn SH, Jang MJ, et al
    Fifteen-year patency and 18-year clinical outcomes after surgical revascularization using saphenous vein composite grafts to total arterial grafts.
    J Thorac Cardiovasc Surg. 2026;172:369-378.
    PubMed         Abstract available


    JAMA

  65. ANDERER S
    Ischemic Heart Disease Deaths Increasingly Tied to BMI, Hyperglycemia.
    JAMA. 2026 Jul 31. doi: 10.1001/jama.2026.9497.
    PubMed        


    Lancet

  66. RUEL M, Nambala S, Guo MH, Verevkin A, et al
    Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.
    Lancet. 2026 Jul 31:S0140-6736(26)01288-2. doi: 10.1016/S0140-6736(26)01288.
    PubMed         Abstract available


    N Engl J Med

  67. SKEITH L, Bates SM
    Sex Hormone Influences on Cardiovascular Risk. Reply.
    N Engl J Med. 2026;395:10.
    PubMed        

  68. BONNET F, Vaduva P
    Sex Hormone Influences on Cardiovascular Risk.
    N Engl J Med. 2026;395:519-520.
    PubMed        

  69. DOUXFILS J, Creinin MD, Foidart JM
    Sex Hormone Influences on Cardiovascular Risk.
    N Engl J Med. 2026;395:518-519.
    PubMed        

  70. LEE YJ, Kim BK
    LDL Cholesterol Targeting in Cardiovascular Disease. Reply.
    N Engl J Med. 2026;395:516.
    PubMed        

  71. CRAVEDI P, Ruggenenti PL, Remuzzi G
    LDL Cholesterol Targeting in Cardiovascular Disease.
    N Engl J Med. 2026;395:515-516.
    PubMed        

  72. ZHU Q, Wang S
    LDL Cholesterol Targeting in Cardiovascular Disease.
    N Engl J Med. 2026;395:515.
    PubMed        

  73. VAN TWIST DJL, Beeren J
    LDL Cholesterol Targeting in Cardiovascular Disease.
    N Engl J Med. 2026;395:514-515.
    PubMed        

  74. HOWELL RR, Jones KW
    LDL Cholesterol Targeting in Cardiovascular Disease.
    N Engl J Med. 2026;395:514.
    PubMed        

  75. MALLIDI J, Lotif A
    LDL Cholesterol Targeting in Cardiovascular Disease.
    N Engl J Med. 2026;395:513-514.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum